Sommaire

• • ·Editorial Board

    Page :i

    

• Original Articles

  • ·Screening for antimicrobial-resistant Gram-negative bacteria in hospitalised patients, and risk of progression from colonisation to infection: Systematic review

    Page :119-130

    Guglielmo Arzilli, Giuditta Scardina, Virginia Casigliani, Davide Petri, Andrea Porretta, Marco Moi, Ersilia Lucenteforte, Jordi Rello, Pierluigi Lopalco, Angelo Baggiani, Gaetano Pierpaolo Privitera, Lara Tavoschi

    Résumé Résumé Plan Plan   
  • ·Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score

    Page :131-135

    Sarah E. Battle, Matthew Shuping, Sarah Withers, Julie A. Justo, P. Brandon Bookstaver, Majdi N. Al-Hasan

    Résumé Résumé Plan Plan  
  • ·Invasive serogroup B meningococci in England following three years of 4CMenB vaccination – First real-world data

    Page :136-144

    Jay Lucidarme, Xilian Bai, Aiswarya Lekshmi, Stephen A. Clark, Laura Willerton, Sonia Ribeiro, Helen Campbell, Laura Serino, Rosita De Paola, Ann Holland, Jennifer Louth, Mary E. Ramsay, Shamez N. Ladhani, Ray Borrow

    Résumé Résumé Plan Plan   
  • ·Burden of influenza disease in children under 2 years of age hospitalized between 2011 and 2020 in France

    Page :145-150

    Célia Tillard, Emmanuel Chazard, Karine Faure, Stéphanie Bartolo, Alain Martinot, François Dubos

    Résumé Résumé Plan Plan   
  • ·Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season

    Page :151-157

    Naoki Tani, Naoki Kawai, Yong Chong, Takuma Bando, Norio Iwaki, Seizaburo Kashiwagi, Hideyuki Ikematsu

    Résumé Résumé Plan Plan  
  • ·Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies

    Page :158-170

    S.A. Behnood, R. Shafran, S.D. Bennett, A.X.D. Zhang, L.L. O'Mahoney, T.J. Stephenson, S.N. Ladhani, B.L. De Stavola, R.M. Viner, O.V. Swann

    Résumé Résumé Plan Plan   
  • ·SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study

    Page :171-178

    Willem A. Mak, Johannes G.M. Koeleman, Marijke van der Vliet, Frans Keuren, David S.Y. Ong

    Résumé Résumé Plan Plan  
  • ·Post-sequelae one year after hospital discharge among older COVID-19 patients: A multi-center prospective cohort study

    Page :179-186

    Xiaoyu Fang, Chao Ming, Yuan Cen, Hao Lin, Kegang Zhan, Sha Yang, Li Li, Guoqiang Cao, Qi Li, Xiangyu Ma

    Résumé Résumé Plan Plan   
  • ·MAMDC2, a gene highly expressed in microglia in experimental models of Alzheimers Disease, positively regulates the innate antiviral response during neurotropic virus infection

    Page :187-204

    Yiliang Wang, Weisheng Luo, Xiaohui Wang, Yuying Ma, Lianzhou Huang, Yifei Wang

    Résumé Résumé Plan Plan   
  • ·The burden of respiratory syncytial virus in children under 5 years of age in Norway

    Page :205-215

    Lise Beier Havdal, Håkon Bøås, Terese Bekkevold, Anne-Marte Bakken Kran, Astrid Elisabeth Rojahn, Ketil Størdal, Sara Debes, Henrik Døllner, Svein Arne Nordbø, Bjørn Barstad, Elisebet Haarr, Liliana Vázquez Fernández, Britt Nakstad, Christopher Inchley, Elmira Flem

    Résumé Résumé Plan Plan   
  • ·Sensitivity and specificity of surveillance case definitions in detection of influenza and respiratory syncytial virus among hospitalized patients, New Zealand, 2012–2016

    Page :216-226

    William Davis, Jazmin Duque, Q. Sue Huang, Natalie Olson, Cameron C. Grant, E. Claire Newbern, Mark Thompson, Ben Waite, Namrata Prasad, Adrian Trenholme, Eduardo Azziz-Baumgartner

    Résumé Résumé Plan Plan  
  • ·Cerebral aspergillosis in the era of new antifungals: The CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS)

    Page :227-236

    A. Serris, J. Benzakoun, F. Danion, R. Porcher, R. Sonneville, M. Wolff, S. Kremer, V Letscher-Bru, A Fekkar, G. Hekimian, V. Pourcher, M-E. Bougnoux, S. Poirée, F. Ader, F. Persat, Francois Cotton, Pierre Tattevin, J.-P. Gangneux, L. Lelièvre, S. Cassaing, Fabrice Bonneville, S. Houze, Stephane Bretagne, R. Herbrecht, O. Lortholary, O. Naggara, F. Lanternier, the CEREAL study group

    Résumé Résumé Plan Plan   
  • ·T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option

    Page :237-247

    Sibylle C. Mellinghoff, Martin Thelen, Christiane Bruns, Maria Garcia-Marquez, Pia Hartmann, Tatjana Lammertz, Jonas Lehmann, Angela Nowag, Jannik Stemler, Kerstin Wennhold, Oliver A. Cornely, Michael S. von Bergwelt-Baildon, Hans A. Schlößer

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Correspondence on “dengue and dementia risk: A nationwide longitudinal study” by Chu et al.

    Page :248-288

    Amy Ker, Pei-En Kao, Yao-Min Hung, Renin Chang, James Cheng-Chung Wei

    Plan Plan
  • ·Suspected reinfections of SARS-COV-₂ in Khyber Pakhtunkhwa, Pakistan – analysis of province-wide testing database

    Page :248-288

    Habab Ali Ahmad, Haleema Khan, Muhammad Shahzad, Zia ul Haq, Steve Harakeh, Yasar Mehmood Yousafzai

    Résumé Résumé Plan Plan   
  • ·Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study

    Page :248-288

    A. Atti, M. Ferrari, J. Castillo-Olivares, E.J.M. Monk, R. Gopal, M. Patel, K. Hoschler, M.J. Cole, A. Semper, J. Hewson, A.D. Otter, S. Foulkes, J. Islam, M. Mirfenderesky, S. Jain, J. Murira, C. Favager, E. Nastouli, M.A. Chand, C.S. Brown, J.L. Heeney, T. Brooks, V.J. Hall, S. Hopkins, M. Zambon

    Plan Plan  
  • ·Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine

    Page :248-288

    Valentine Marie Ferré, Samuel Lebourgeois, Reyene Menidjel, Gilles Collin, Houssem Redha Chenane, Manuella Onambele Guindi, Yazdan Yazdanpanah, Jean-François Timsit, Charlotte Charpentier, Diane Descamps, Nadhira Fidouh, Benoit Visseaux

    Plan Plan  
  • ·Antibody titers and protection against a SARS-CoV-2 infection

    Page :248-288

    Chloé Dimeglio, Fabrice Herin, Guillaume Martin-Blondel, Marcel Miedougé, Jacques Izopet

    Plan Plan  
  • ·Endogenous Candida endophthalmitis: Has it been discerned from a cotton wool spot in the retina?

    Page :248-288

    Mark P. Breazzano

    Plan Plan
  • ·Integrated mobile container PCR laboratory (IMCPL): A novel strategy to reduce unnecessary rapid antigen testing

    Page :248-288

    Ming Li, Jie Zhao, Hui Zhang, Jiang Liu, Xiangshi Fan, Xiaohui Bai, Zhiming Lu

    Plan Plan  
  • ·Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: A prospective cohort study of vaccinated and unvaccinated healthcare workers

    Page :248-288

    Alessandra Luna-Muschi, Igor C. Borges, Elizabeth de Faria, Antonio S. Barboza, Fernando L. Maia, Mariana D. Leme, Ana Rubia Guedes, Maria Cassia Mendes-Correa, Esper G. Kallas, Aluísio C. Segurado, Alberto J.S. Duarte, Carolina S. Lazari, Pamela S. Andrade, Flávia C.S. Sales, Ingra M. Claro, Ester C. Sabino, Anna S. Levin, Silvia F. Costa

     
  • ·Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis

    Page :248-288

    Ling Zuo, Guangyu Ao, Yushu Wang, Ming Gao, Xin Qi

    Résumé Résumé Plan Plan   
  • ·Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites

    Page :248-288

    Shizheng Qiu, Donghua Wang, Yu Zhang, Yang Hu

    
  • ·SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition

    Page :248-288

    Luke B Snell, Ali R Awan, Themoula Charalampous, Adela Alcolea-Medina, Sam T Douthwaite, Jonathan D Edgeworth, Gaia Nebbia

    
  • ·Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients

    Page :248-288

    Alejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Aida Izquierdo-Martínez, Cristina Llarena-Barroso, Beatriz Jaenes-Barrios, Nieves Mesa-Plaza, María Toledano-Macías, Guillermo Soria Fernández-Llamazares, Laura Molina-Esteban, Jaime García de Tena, Santiago Prieto-Menchero, Sonia Gonzalo-Pascua, Juan Víctor San Martín-López, David Bernal-Bello

    Résumé Résumé Plan Plan
  • ·Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance

    Page :248-288

    Aurélie Guigon, Emmanuel Faure, Chloé Lemaire, Marie-Charlotte Chopin, Claire Tinez, Ady Assaf, Mouna Lazrek, Didier Hober, Laurence Bocket, Ilka Engelmann, Enagnon Kazali Alidjinou

    
  • ·False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden

    Page :248-288

    Andreas Kretschmer, Annelene Kossow, Barbara Grüne, Oliver Schildgen, Tim Mathes, Verena Schildgen

     
  • ·COVID-19 case-clusters and transmission chains in the communities in Japan

    Page :248-288

    Yuki Furuse, Naho Tsuchiya, Reiko Miyahara, Ikkoh Yasuda, Eiichiro Sando, Yura K Ko, Takeaki Imamura, Konosuke Morimoto, Tadatsugu Imamura, Yugo Shobugawa, Shohei Nagata, Atsuna Tokumoto, Kazuaki Jindai, Motoi Suzuki, Hitoshi Oshitani

    Plan Plan   
  • ·Predicting COVID-19 incidence in Pakistan: It's time to act now!

    Page :248-288

    Muhammad Imran Khan, Humera Qureshi, Aamer Ali Khattak, Usman Ayub Awan

    Plan Plan  
  • ·Post-COVID functional limitations on daily living activities are associated with symptoms experienced at the acute phase of SARS-CoV-2 infection and internal care unit admission: A multicenter study

    Page :248-288

    César Fernández-de-las-Peñas, José D. Martín-Guerrero, Esperanza Navarro-Pardo, Jorge Rodríguez-Jiménez, Oscar J. Pellicer-Valero

    Plan Plan
  • ·A brief smartphone-based intervention significantly improved pre-exposure prophylaxis adherence among Chinese men sex with men: Findings of a randomized controlled trial

    Page :248-288

    Zhaozhen Liu, Rantong Bao, Xiangjun Zhang, Hongyi Wang, Zixin Wang, Jing Zhang, Zhenxing Chu, Qinghai Hu, Hanzhu Qian, Weiming Tang, Zhili Hu, Shangcao Li, Hang Li, Haibo Ding, Wenqing Geng, Yongjun Jiang, Hong Shang, Junjie Xu

      

• Letters to the Editor Online Only

  • ·SARS-CoV-2 serological cross-reactivity testing in Brazilian blood donors, October-December, 2019

    Page :e1

    Victoria Simionatto Zucherato, Mariane Evaristo, Elaine Vieira Santos, Ralyria Mello, Érika Donizetti Candido, Danielle Bastos Araujo, Danielle Bruna Leal de Oliveira, Edson Luiz Durigon, Marta Giovanetti, Luiz Carlos Júnior Alcantâra, Daiani Cristina Cilião-Alves, Rodrigo Haddad, Dimas Tadeu Covas, Simone Kashima, Svetoslav Nanev Slavov

    Plan Plan
  • ·Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic

    Page :e3

    Lorna S Finch, Adrian Harris, Catherine Lester, Dawn Veal, Karen Jones, Jamie Fulton, Lewis Jones, Matt Lee, Tony Walker, Mike Rossiter, Matt Cross, Simon Kemp, Tom Fletcher, Emily R Adams

    Résumé Résumé Plan Plan  
  • ·Characteristics of  SARS-CoV-2 super-spreaders in Japan

    Page :e6

    Tomoki Kawahara, Yutaka Ueki, Nobutoshi Nawa, Shigeru Miyamae, Mariko Hanafusa, Yuki Goto, Shuji Tohda, Takeo Fujiwara

    Plan Plan  
  • ·The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community

    Page :e10

    Amal Al Maani, Adil Al Wahaibi, Weam Nazer, Najla Al-Zadjali, Jokha Al Rawahi, Iman Al-Beloushi, Jabir Al-Sooti, Abdullah Alqayoudhi, Seif Al-Abri

    Plan Plan   
  • ·Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China

    Page :e13

    Yiman Geng, Leiliang Zhang

    Résumé Résumé  
  • ·Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China

    Page :e16

    Bo Xu, Fu-qiang Ma, Cong He, Zi-qi Wu, Cun-yu Fan, He-rong Mao, Ji-xian Zhang, Min Yang, Zuo-wei Hu

    Plan Plan  
  • ·Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease

    Page :e19

    Renxi Wang

    Résumé Résumé Plan Plan  
  • ·Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases

    Page :e22

    Narcis-George Manolache, Vasile Ursachi, Anaïs Scohy, Charlotte Desmet, Jean Cyr Yombi, Adrien Nzeusseu Toukap, Maria Simona Stoenoiu

     
  • ·Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection

    Page :e24

    Tatyane de Souza Cardoso Quintão, Svetoslav Nanev Slavov, Pâmela Maria de Oliveira, Rafael dos Santos Bezerra, Évelin Mota Cassemiro, Priscilla Pedrette de Melo Alves, Carolina Carvalho Gontijo, Fabiano dos Anjos Pereira Martins, Helen da Costa Gurgel, Elza Ferreira Noronha, Walter Massa Ramalho, Wildo Navegantes de Araújo, Alex Leite Pereira, Rodrigo Haddad

    Plan Plan  
  • ·Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients

    Page :e27

    Alexander J Mentzer, Tim James, Mirak Yongya, Stuart Cox, Kevin Paddon, Brian Shine, Jordan Bowen, Alex Novak, Julian C Knight, James N Fullerton

    Plan Plan